Show simple item record

dc.contributor.authorGiles, Sally J; orcid: 0000-0003-1623-6029; email: sally.giles@manchester.ac.uk
dc.contributor.authorPanagioti, Maria
dc.contributor.authorRiste, Lisa
dc.contributor.authorCheraghi-Sohi, Sudeh
dc.contributor.authorLewis, Penny
dc.contributor.authorAdeyemi, Isabel
dc.contributor.authorDavies, Karen
dc.contributor.authorMorris, Rebecca
dc.contributor.authorPhipps, Denham
dc.contributor.authorDickenson, Christine
dc.contributor.authorAshcroft, Darren
dc.contributor.authorSanders, Caroline
dc.date.accessioned2021-10-18T00:36:44Z
dc.date.available2021-10-18T00:36:44Z
dc.date.issued2021-09-15
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/626121/article.pdf?sequence=2
dc.identifier.citationSystematic reviews, volume 10, issue 1, page 248
dc.identifier.urihttp://hdl.handle.net/10034/626121
dc.descriptionFrom Europe PMC via Jisc Publications Router
dc.descriptionHistory: ppub 2021-09-01, epub 2021-09-15
dc.descriptionPublication status: Published
dc.descriptionFunder: National Institute for Health Research
dc.description.abstract<h4>Background</h4>The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people.<h4>Methods/design</h4>Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics.<h4>Discussion</h4>The review will summarise the literature relating to medication safety and visual impairment.
dc.languageeng
dc.rightsLicence for this article: cc by
dc.sourceessn: 2046-4053
dc.sourcenlmid: 101580575
dc.sourceissn: 2046-4053
dc.subjectVisual Impairment
dc.subjectMedication Safety
dc.titleVisual impairment and medication safety: a protocol for a scoping review.
dc.typearticle
dc.date.updated2021-10-18T00:36:44Z


Files in this item

Thumbnail
Name:
article.pdf
Size:
659.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record